glycin
decarboxylas
gldc
priorit
candid
suscept
gene
sever
influenza
human
higher
express
gldc
deriv
genet
variat
may
confer
higher
risk
sever
infect
sought
character
gldc
function
suscept
gene
gldc
may
intrins
regul
antivir
respons
therebi
impact
viral
replic
diseas
outcom
demonstr
gldc
inhibitor
aoaa
sirna
deplet
boost
ifnband
ifnstimul
gene
isg
combin
polyi
c
stimul
gldc
inhibit
deplet
significantli
amplifi
antivir
respons
type
ifn
isg
upon
viral
infect
suppress
replic
virus
consist
gldc
overexpress
significantli
promot
viral
replic
due
attenu
antivir
respons
moreov
gldc
inhibit
balbc
mice
recapitul
amplifi
antivir
respons
suppress
viral
growth
aoaa
provid
potent
protect
infect
mice
lethal
infect
compar
standard
antivir
influenza
virus
collect
gldc
regul
cellular
antivir
respons
orchestr
viral
growth
gldc
function
suscept
gene
sever
influenza
human
human
influenza
virus
season
influenza
virus
pandem
viru
hereinaft
usual
lead
upper
respiratori
infect
mildtomoder
symptom
albeit
occasion
caus
lifethreaten
pneumonia
patient
chronic
underli
diseas
even
healthi
individu
novel
avian
viru
caus
recurr
outbreak
human
infect
china
sinc
human
infect
mostli
manifest
rapidli
progress
pneumonia
show
variabl
suscept
among
individu
contribut
human
genet
variat
suscept
sever
influenza
clearli
demonstr
earlier
epidemiolog
studi
albright
et
al
variabl
suscept
infect
diversifi
diseas
sever
pandem
infect
prompt
us
deciph
genet
suscept
identifi
host
gene
predispos
sever
influenza
ie
sever
infect
identifi
host
suscept
gene
sever
influenza
previous
conduct
genomewid
associ
studi
gwa
two
studi
cohort
cohort
includ
patient
versu
healthi
control
heavili
expos
viru
chen
et
al
cohort
consist
sever
patient
versu
control
patient
mild
infect
zhou
et
al
priorit
candid
suscept
gene
sever
infect
integr
gwa
discoveri
express
quantit
trait
loci
eqtl
analysi
strategi
wide
use
identifi
trait
gene
target
musunuru
et
al
zhu
et
al
glycin
decarboxylas
gldc
emerg
potenti
suscept
gene
studi
cohort
gldc
p
protein
glycin
cleavag
system
bind
glycin
enabl
transfer
methylamin
group
glycin
protein
interestingli
zhang
et
al
uncov
novel
role
gldc
promot
pyrimidin
biosynthesi
drive
tumorigenesi
lung
cancer
zhang
et
al
wellestablish
cellular
pyrimidin
metabol
profoundli
affect
viru
propag
dihydroorot
dehydrogenas
dhodh
enzym
catalyz
fourth
step
de
novo
pyrimidin
biosynthesi
repetit
identifi
cellular
target
highthroughput
screen
antivir
conduct
sever
group
includ
us
hoffmann
et
al
wang
et
al
cheung
et
al
deplet
cellular
pyrimidin
inhibit
replic
array
rna
virus
dna
virus
retrovirus
interestingli
lucashourani
et
al
report
pyrimidin
depriv
suppress
viral
growth
amplifi
innat
immun
respons
rather
deplet
nucleotid
precursor
viral
genom
replic
assum
previous
hoffmann
et
al
consolid
prior
knowledg
find
genet
associ
studi
hypothes
link
gldc
innat
immun
may
impact
viral
growth
underli
genet
associ
gldc
sever
infect
perform
seri
vitro
vivo
experi
establish
gldc
function
suscept
gene
sever
influenza
order
identifi
host
gene
predispos
sever
pandem
influenza
conduct
smallscal
gwa
sever
patient
control
patient
mild
diseas
intron
snp
gldc
significantli
associ
suscept
sever
infect
verifi
genet
associ
larger
cohort
includ
sever
patient
mild
control
carrier
aa
ag
genotyp
exhibit
higher
risk
sever
infect
carrier
genotyp
gg
tabl
chose
valid
sinc
snp
express
quantit
trait
loci
eqtl
lymphoblast
cell
line
lcl
deriv
chines
japanes
respect
fig
eqtl
human
lung
tissu
fig
hao
et
al
specif
differenti
express
level
gldc
significantli
correl
genotyp
lcl
human
lung
tissu
risk
variant
correspond
higher
gldc
express
interestingli
genet
associ
gldc
sever
influenza
replic
cohort
includ
patient
control
healthi
poultri
worker
snp
high
linkag
equilibrium
multipl
ethnic
group
fig
significantli
associ
suscept
human
infect
tabl
risk
allel
g
high
linkag
allel
significantli
overrepres
patient
control
carrier
gg
ga
genotyp
confer
twofold
higher
risk
infect
compar
carrier
genotyp
aa
collect
integr
diseas
associ
eqtl
dataset
suggest
higher
gldc
express
encod
genet
variat
may
confer
predisposit
infect
sever
infect
substanti
gldc
function
suscept
gene
search
molecular
mechan
underli
genet
associ
consolid
exist
knowledg
hypothes
link
gldc
innat
immun
gldc
probabl
act
intrins
regul
host
antivir
respons
due
role
de
novo
pyrimidin
biosynthesi
zhang
et
al
therebi
impact
viral
growth
diseas
outcom
upon
viru
exposur
establish
link
gldc
modul
pyrimidin
biosynthesi
regul
antivir
respons
perform
two
set
experi
firstli
intend
verifi
role
gldc
cellular
pyrimidin
biosynthesi
shown
previous
zhang
et
al
treatment
gldc
inhibitor
aminooxi
acet
acid
aoaa
cell
h
amount
thymidin
one
pyrimidin
compound
detect
lcmsm
gldc
inhibitor
aoaa
appear
diminish
cellular
pool
thymidin
nucleosid
dosedepend
manner
fig
verifi
role
gldc
intrins
regul
pyrimidin
biosynthesi
report
previous
secondli
assess
whether
gldc
inhibit
boost
innat
antivir
respons
end
cell
transfect
ifnb
luciferas
report
plasmid
treat
aoaa
mocktreat
h
appli
luciferas
assay
howev
aoaa
treatment
unabl
activ
ifnb
luciferas
report
gene
fig
lgml
poli
c
postul
aoaa
may
requir
addit
signal
trigger
ifn
activ
similar
pyrimidin
inhibitor
previou
studi
lucashourani
et
al
set
scenario
transfect
ifnb
report
plasmid
poli
c
agonist
pattern
recognit
receptor
prr
rigi
subsequ
transfect
along
aoaa
treatment
poli
c
transfect
ifnb
report
gene
slightli
activ
notabl
combin
poli
c
stimul
aoaa
treatment
amplifi
ifnb
activ
significantli
higher
level
mock
treatment
evalu
effect
gldc
inhibit
cell
line
stabli
carri
interferonstimul
respons
element
isr
report
gene
isr
conserv
dna
sequenc
element
harbor
promot
interferonstimul
gene
isg
likewis
aoaa
treatment
alon
unabl
activ
isr
report
gene
howev
simultan
poli
c
stimul
aoaa
boost
isr
activ
significantli
higher
level
korigi
cell
gener
cell
stabl
knockout
rigi
gene
cell
aoaaamplifi
activ
isr
report
gene
abolish
fig
indic
requir
rigi
prr
signal
isr
activ
ascertain
role
gldc
modul
type
ifn
product
deplet
gldc
gldc
sirna
follow
poli
c
transfect
h
poli
c
stimul
cell
cellfre
cultur
media
harvest
shown
fig
gdlc
express
decreas
around
gldcdeplet
cell
compar
scrambl
sirnatransfect
cell
gldcdeplet
cell
ifna
mrna
express
significantli
upregul
consist
ifna
secret
cultur
media
also
elev
significantli
togeth
demonstr
gldc
inhibit
could
suppress
pyrimidin
biosynthesi
combin
prr
stimul
gldc
inhibit
deplet
amplifi
induct
type
ifn
isg
addit
gldc
inhibit
trigger
activ
type
ifn
isg
requir
prr
signal
evalu
whether
gldc
inhibit
affect
replic
influenza
virus
inhibit
boost
type
ifn
isg
shown
fig
aoaa
treatment
significantli
decreas
viral
load
cell
lysat
cellfre
cultur
media
supernat
virusand
virusinfect
cell
aoaa
treatment
significantli
reduc
viral
titer
log
unit
cell
h
postinfect
hpi
fig
aoaamedi
suppress
viral
replic
promin
cell
treatment
lm
aoaa
significantli
decreas
viral
titer
around
log
unit
hpi
fig
expect
aoaaamplifi
antivir
respons
contribut
decreas
viral
replic
cell
aoaa
treatment
significantli
augment
product
type
ifn
ifna
ifnb
isg
dosedepend
pattern
fig
accord
stronger
suppress
viral
growth
boost
antivir
respons
pronounc
cell
hpi
aoaa
treatment
trigger
intens
extens
upregul
type
ifn
isg
includ
pkr
dosedepend
manner
fig
antivir
molecul
also
show
consist
upregul
profil
hpi
fig
also
perform
cell
viabil
assay
exclud
possibl
aoaamedi
suppress
viral
growth
relat
cytotox
fig
aforement
dhodh
import
enzym
de
novo
pyrimidin
biosynthesi
pathway
brequinar
wellknown
inhibitor
dhodh
liu
et
al
shown
amplifi
express
isg
lucashourani
et
al
hypothes
brequinar
could
recapitul
effect
aoaa
viral
replic
two
compound
truli
target
enzym
pyrimidin
biosynthesi
pathway
expect
brequinar
treatment
prompt
heighten
induct
ifna
isg
significantli
suppress
replic
fig
result
lend
support
find
antivir
effect
aoaa
attribut
pyrimidin
depriv
mediat
gldc
inhibit
verifi
role
gldc
viral
replic
multicycl
replic
viru
perform
cell
gldc
sirna
deplet
intracellular
cell
lysat
extracellular
supernat
viral
load
significantli
lower
gldc
sirnatransfect
cell
control
sirnatransfect
cell
hpi
fig
viral
titer
gldcdeplet
cell
also
significantli
lower
control
cell
furthermor
amplifi
antivir
respons
observ
aoaa
treatment
replic
gldcdeplet
cell
express
level
ifna
ifnb
significantli
augment
gldcdeplet
cell
control
cell
fig
sever
isg
eg
significantli
upregul
former
collect
gldc
inhibit
deplet
significantli
suppress
replic
viru
via
amplifi
antivir
respons
establish
role
gldc
replic
influenza
virus
transfect
gldc
express
plasmid
vector
inocul
viru
h
posttransfect
gldc
overexpress
significantli
increas
viral
load
cell
fig
intracellular
viral
load
significantli
higher
gldcoverexpress
cell
control
cell
hpi
hpi
viral
load
cultur
media
higher
former
latter
consist
significantli
attenu
antivir
respons
includ
type
ifn
isg
observ
gldcoverexpress
cell
compar
control
cell
fig
enhanc
viral
replic
blunt
antivir
respons
also
observ
cell
gldc
overexpress
fig
therefor
gldc
overexpress
compromis
antivir
respons
promot
viral
replic
effici
gldc
sirna
deplet
gldc
overexpress
illustr
fig
sinc
gldc
affect
growth
influenza
virus
via
modul
antivir
respons
test
whether
oper
viral
infect
end
cell
inocul
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
viru
caus
human
respiratori
infect
h
posttransfect
gldc
express
plasmid
vector
demonstr
gldc
overexpress
significantli
promot
replic
merscov
hpi
fig
indic
gldcorchestr
viral
growth
oper
viral
infect
assess
whether
gldc
inhibit
balbc
mice
recapitul
amplif
antivir
respons
suppress
viral
growth
whether
gldc
inhibit
protect
infect
mice
sever
outcom
three
group
balbc
mice
intranas
inocul
mouseadapt
pandem
viru
intranas
administr
aoaa
zanamivir
pb
three
time
illustr
fig
total
mice
group
monitor
bodi
weight
chang
surviv
rate
day
postinocul
contrast
surviv
rate
pbstreat
mice
aoaatreat
mice
surviv
infect
fig
notabl
aoaa
provid
equival
protect
zanamivir
standard
antivir
influenza
virus
indic
tempor
gldc
inhibit
could
achiev
potent
protect
fatal
infect
pbstreat
mice
lost
bodi
weight
significantli
day
postinocul
bodi
weight
aoaatreat
mice
rebound
day
fig
afterward
bodi
weight
aoaatreat
mice
tend
higher
pbstreat
mice
yet
compar
zanamivirtr
mice
viral
load
viral
titer
lung
tissu
aoaatreat
mice
significantli
lower
pbstreat
mice
day
postinfect
fig
addit
significantli
higher
level
ifna
observ
mous
lung
tissu
day
postinfect
aoaatreat
mice
pbstreat
mice
fig
aoaaamplifi
isg
product
also
observ
mice
viru
antigenposit
cell
mous
lung
abund
pbstreat
mice
aoaatreat
mice
fig
consist
higher
viral
titer
former
exclud
possibl
aoaamedi
reduct
viral
growth
relat
toxic
sinc
mice
intranas
administr
aoaa
consecut
day
exhibit
discern
differ
bodi
weight
loss
comparison
mice
treat
pb
fig
thu
gldc
inhibit
mice
significantli
boost
antivir
respons
decreas
viral
growth
protect
mice
lethal
infect
influenza
virus
caus
mildtomoder
respiratori
ill
patient
occasion
sever
fatal
infect
earlier
b
figur
gldc
inhibit
deplet
activ
type
ifn
isg
cell
cotransfect
pifnbluc
tknanoluc
transfect
poli
c
lgml
simultan
treat
aoaa
lm
cell
lyse
luciferas
assay
h
korigi
cell
carri
isr
report
gene
transfect
treat
indic
concentr
poli
c
aoaa
respect
triplic
h
cellfre
supernat
use
luciferas
assay
data
present
normal
luciferas
activ
rel
mock
poli
c
transfect
mock
aoaa
treatment
data
shown
repres
three
independ
experi
n
b
cell
transfect
gldc
sirna
sigldc
scrambl
sirna
sictrl
transfect
poli
c
lgml
h
cell
lysat
media
harvest
detect
mrna
express
gldc
ifna
rtqpcr
measur
ifna
product
elisa
respect
data
shown
repres
three
independ
experi
n
epidemiolog
studi
clearli
demonstr
genet
contribut
fatal
influenza
infect
albright
et
al
addit
host
genet
variat
found
associ
develop
sever
pneumonia
influenza
infect
zuniga
et
al
sought
identifi
suscept
gene
may
account
interindividu
variabl
sever
influenza
gwa
previous
conduct
cohort
pandem
cohort
besid
genet
contribut
emerg
evid
suggest
broadli
protect
immun
respons
due
childhood
infect
provid
longterm
crossimmun
among
differ
ha
subtyp
especi
phylogenet
group
gostic
et
al
first
glanc
suscept
infect
suscept
sever
infect
equival
issu
fact
infect
sever
infect
essenti
share
patholog
ie
viral
pneumonia
lethal
consequ
influenza
nikolaidi
et
al
overal
pandem
virus
exhibit
bind
specif
humantyp
sialic
acid
receptor
zhou
et
al
virus
tend
replic
activ
human
bronchu
lung
tissu
nonhuman
primat
replic
pandem
viru
mainli
affect
upper
respiratori
tract
watanab
et
al
hand
virus
bind
humantyp
sialic
acid
receptor
aviantyp
receptor
mainli
distribut
human
airway
epithelium
lower
respiratori
epithelium
respect
accordingli
viru
infect
epitheli
cell
human
airway
lower
respiratori
tract
includ
alveoli
knepper
et
al
zhou
et
al
replic
effici
upper
lower
respiratori
tract
nonhuman
primat
thu
biolog
characterist
pandem
viru
viru
larg
determin
predilect
pandem
infect
upper
respiratori
tract
infect
viru
like
develop
lower
respiratori
tract
infect
given
exist
risk
factor
facilit
viral
growth
access
lower
respiratori
b
figur
gldc
inhibit
suppress
viral
replic
b
cell
inocul
b
virus
moi
cell
treat
aoaa
lm
triplic
prior
inocul
indic
hour
postinocul
cell
lysat
cellfre
media
supernat
harvest
detect
viral
load
rtqpcr
assay
viral
titrat
plaqu
assay
respect
data
shown
repres
least
three
independ
experi
n
graph
show
mean
ae
sd
unpair
ttest
use
data
analysi
last
decad
gwa
evolv
identifi
genet
variant
associ
diseas
reveal
function
variant
underli
diseas
associ
unbias
genomewid
interrog
genet
variat
associ
diseas
clinic
trait
gwa
could
provid
novel
biolog
insight
diseas
pathophysiolog
uncov
new
molecul
pathway
relat
diseas
gwa
diseas
suscept
demonstr
major
associ
signal
involv
noncod
singl
nucleotid
variant
socal
regulatori
variant
modul
gene
express
knight
recognit
regulatori
polymorph
regul
gene
express
genomewid
correl
genet
variant
gene
express
systemat
interrog
establish
variou
human
tissu
known
quantit
trait
loci
eqtl
fairfax
knight
eqtl
transform
gwa
associ
variant
candid
gene
brought
forward
function
valid
experi
vitro
andor
vivo
zhu
et
al
studi
intersect
genet
associ
eqtl
dataset
suggest
higher
gldc
express
encod
genet
variat
may
predispos
affect
individu
sever
infect
substanti
gldc
function
suscept
gene
sever
influenza
extens
search
possibl
b
figur
amplifi
antivir
respons
contribut
aoaamedi
inhibit
viral
replic
b
cell
inocul
b
virus
cell
treat
aoaa
lm
prior
inocul
indic
hour
postinocul
cell
lysat
harvest
detect
express
level
antivir
molecul
rtqpcr
assay
data
shown
repres
least
three
independ
experi
n
graph
show
mean
ae
sd
unpair
ttest
use
data
analysi
mechan
gldc
modul
pyrimidin
biosynthesi
zhang
et
al
meanwhil
pyrimidin
depriv
suppress
viral
replic
via
boost
antivir
innat
immun
lucashourani
et
al
evid
inspir
us
hypothes
subsequ
uncov
gldcpyrimidin
biosynthesisinn
immun
axi
verifi
gldc
inhibitor
aoaa
substanti
suppress
pyrimidin
biosynthesi
fig
aoaa
alon
unabl
activ
ifnb
isr
luciferas
report
gene
combin
stimul
aoaa
significantli
activ
report
gene
fig
accordingli
aoaaamplifi
isr
activ
rigi
depend
sinc
activ
abolish
rigiknockout
cell
thu
uncov
novel
role
gldc
intrins
regul
innat
immun
due
effect
modul
pyrimidin
biosynthesi
addit
aoaa
treatment
gldc
sirna
knockdown
invari
suppress
replic
viru
due
amplifi
induct
type
ifn
isg
fig
consist
gldc
overexpress
promot
viral
growth
via
compromis
antivir
respons
fig
result
establish
gldc
import
host
gene
replic
influenza
virus
due
gldc
pyrimidin
biosynthesisinn
immun
axi
addit
axi
may
function
viral
infect
sinc
gldc
overexpress
also
significantli
enhanc
replic
merscov
fig
demonstr
balbc
mice
aoaamedi
amplif
antivir
respons
suppress
viral
growth
fig
even
promin
vitro
effect
cell
outperform
aoaa
vivo
believ
attribut
aoaatrigg
antivir
cascad
aforement
aoaaamplifi
ifn
isg
respons
elicit
context
viru
infect
simultan
stimul
prr
howev
cytopath
effect
caus
replic
virus
would
gradual
compromis
cell
viabil
cellular
antivir
respons
thu
virusinfect
cell
aoaa
limit
window
boost
antivir
respons
cell
overridden
replic
virus
howev
infect
cell
repres
small
percentag
mous
airway
larg
amount
uninfect
healthi
cell
benefit
aoaaamplifi
antivir
respons
thu
aoaaamplifi
antivir
respons
favor
exemplifi
infect
mice
infect
cell
conceiv
differenti
gldc
express
encod
genet
variat
probabl
modest
effect
could
magnifi
virusinfect
individu
substanti
affect
suscept
sever
influenza
influenza
virus
famili
pathogen
pose
signific
threat
public
health
global
numer
system
target
screen
perform
vitro
identifi
import
host
gene
requir
viral
infect
replic
pathogenesi
karla
et
al
dittmann
et
al
howev
metaanalysi
found
littl
overlap
among
host
factor
identifi
variou
studi
chou
et
al
meanwhil
host
factor
essenti
pathogenesi
influenza
extens
investig
mous
studi
best
character
host
restrict
factor
influenza
virus
vitro
mous
studi
brass
et
al
yount
et
al
everitt
et
al
import
arous
interest
explor
genet
associ
sever
influenza
human
howev
result
variou
studi
controversi
everitt
et
al
mill
et
al
lesson
learn
host
gene
identifi
cellular
mous
studi
may
readili
extrapol
clinic
implic
gene
realli
affect
diseas
present
human
influenza
candid
suscept
gene
sever
influenza
human
select
find
human
studi
howev
gwa
especi
infecti
diseas
notori
confound
mani
factor
case
ad
hindranc
limit
sampl
size
due
infrequ
occurr
sever
influenza
despit
obstacl
reason
import
host
gene
pathogenesi
sever
influenza
may
surviv
consider
variat
human
genet
associ
studi
less
stringent
criteria
p
valu
odd
ratio
appli
filter
associ
variant
express
level
candid
gene
genet
correl
thu
captur
eqtl
analysi
line
reason
gldc
priorit
candid
suscept
gene
sever
influenza
prompt
us
conduct
vitro
mous
studi
valid
gldc
function
suscept
gene
sever
influenza
studi
use
gldc
inhibitor
aoaa
demonstr
role
gldc
antivir
respons
viral
growth
mous
surviv
follow
gldc
sirna
deplet
gldc
overexpress
experi
verifi
aoaamedi
effect
vitro
exclud
possibl
aoaamedi
antivir
effect
relat
cytotox
vitro
vivo
addit
cell
aoaa
act
similarli
inhibitor
dhodh
essenti
enzym
catalyz
pyrimidin
biosynthesi
aoaa
commonli
use
gldc
inhibitor
substrat
analogu
gldc
amino
group
glycin
replac
aminooxi
group
aoaa
occupi
gldc
substratebind
site
inhibit
activ
nakai
et
al
howev
less
promin
effect
mediat
genet
modif
sirna
deplet
overexpress
aoaa
treatment
call
clarif
specif
aoaa
futur
studi
addit
data
coher
reach
conclus
pyrimidin
depriv
mediat
gldc
inhibitiondeplet
could
amplifi
antivir
respons
type
ifn
isg
suppress
viral
replic
reinforc
link
pyrimidin
biosynthesi
pathway
antivir
statu
consist
demonstr
studi
hoffmann
et
al
wang
et
al
cheung
et
al
recent
pyrimidin
inhibitor
identifi
broadspectrum
antivir
found
activ
rigi
chung
et
al
essenti
cellular
sensor
mount
innat
immun
respons
influenza
viru
infect
loo
et
al
howev
detail
mechan
link
pyrimidin
depriv
boost
antivir
respons
definit
requir
studi
genomewid
interrog
genet
variat
human
diseasestrait
gwa
success
identifi
novel
unexpect
pathway
molecul
involv
diseas
process
inform
potenti
therapeut
target
okada
et
al
smemo
et
al
howev
knowledg
gwa
discoveri
infecti
diseas
deliber
corrobor
defin
novel
diseaserel
gene
studi
util
integr
approach
identifi
character
gldc
import
suscept
gene
sever
influenza
find
reveal
biolog
pathway
lead
sever
influenza
also
import
clinic
manag
sever
patient
cell
purchas
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
bovin
serum
fb
gibco
unitsml
penicillin
streptomycin
co
ahong
use
vitro
experi
mouseadapt
strain
ahong
propag
embryon
egg
util
mous
experi
fulllength
cdna
gldc
amplifi
use
primer
pair
ggggtacctatgcagtc
ctgtgccagggcgt
forward
ggtctagactaagaagacg
ccctcttttg
revers
insert
vector
kpnihf
xbai
experi
live
virus
conduct
biosafeti
level
laboratori
upon
institut
approv
overnight
cultur
plate
cell
cotransfect
ng
pifnbluc
siu
et
al
ng
tknanoluc
promega
per
well
h
posttransfect
cell
transfect
poli
c
lgml
invivogen
simultan
treat
indic
concentr
aoaa
sigmaaldrich
ca
incub
h
subsequ
cell
lyse
luciferas
assay
use
dualglo
luciferas
assay
system
promega
victor
multilabel
reader
perkinelm
tm
cell
tm
korigi
cell
invivogen
transfect
poli
c
treat
indic
concentr
aoaa
h
cellfre
media
use
luciferas
assay
use
quantiluc
tm
invivogen
cell
transfect
gldc
sirna
scrambl
sirna
nm
thermo
fisher
scientif
use
lipofectamin
rnaimax
thermo
fisher
scientif
two
day
sirna
transfect
cell
transfect
poli
c
lgml
maintain
dmem
h
cell
cellfre
media
harvest
detect
mrna
express
gldc
ifna
rtqpcr
assay
measur
ifna
product
verikinetm
human
ifn
alpha
elisa
kit
pbl
assay
scienc
respect
cell
plate
either
transfect
gldc
sirna
scrambl
sirna
mention
maintain
day
transfect
ng
vector
per
well
use
lipofectamin
thermo
fisher
scientif
maintain
day
pretreat
variou
concentr
aoaa
h
subsequ
transfect
cell
pretreat
cell
inocul
multipl
infect
moi
cell
maintain
dmem
contain
lgml
tpcktrypsin
bsa
aoaa
experi
variou
concentr
aoaa
supplement
cultur
medium
inocul
indic
time
point
cell
lysat
cellfre
media
harvest
detect
viral
load
cellular
gene
express
viral
titrat
cell
also
inocul
merscov
moi
h
cell
transfect
ng
vector
per
well
infect
cell
maintain
dmem
supplement
bsa
cellfre
cultur
media
harvest
indic
time
point
detect
viral
load
describ
elsewher
femal
balbc
mice
week
old
maintain
standard
biosafeti
level
anim
laboratori
institut
given
access
standard
pellet
feed
water
ad
libitum
anim
experi
hous
husbandri
follow
oper
procedur
approv
committe
use
live
anim
teach
research
univers
hong
follow
protocol
ensur
weight
loss
exceed
mous
bodi
weight
interven
prevent
unnecessari
suffer
euthanasia
anim
state
surviv
possibl
regim
mous
experi
illustr
fig
mice
randomli
divid
three
group
inocul
ahong
mouseadapt
strain
pandem
viru
zheng
et
al
mice
anesthet
intraperiton
inject
ketaminexylazin
cocktail
contain
mgkg
ketamin
mgkg
xylazin
day
prior
inocul
h
day
postinocul
mice
intranas
administ
either
aoaa
mgkg
weight
zanamivir
mgkg
weight
pb
volum
anesthesia
mice
n
respect
treat
aoaa
zanamivir
pb
monitor
daili
bodi
weight
surviv
day
inocul
three
mice
aoaatreat
group
pbstreat
group
sacrif
day
viral
challeng
half
lung
tissu
collect
homogen
quantif
viral
growth
antivir
gene
express
half
fix
pfa
tissu
process
immunofluoresc
stain
cell
lysat
homogen
mous
lung
tissu
appli
rna
extract
follow
revers
transcript
use
virusspecif
primer
oligo
dt
result
cdna
use
qpcr
assay
measur
viral
load
express
level
cellular
gene
describ
previous
cellfre
media
infect
cell
supernat
homogen
mous
lung
tissu
appli
viral
rna
extract
purelink
viral
rnadna
mini
kit
thermo
fisher
scientif
rtqpcr
quantif
viral
load
absolut
quantif
use
plasmid
express
conserv
region
iav
gene
qpcr
primer
list
appendix
tabl
viral
titer
cultur
media
supernat
homogen
mous
tissu
detect
plaqu
assay
mdck
cell
zhou
et
al
western
blot
immunofluoresc
stain
cell
transfect
plasmid
sirna
lyse
ripa
lysi
buffer
thermo
fisher
scientif
proteas
inhibitor
author
embo
molecular
medicin
cocktail
roch
appli
detect
gldc
protein
use
antigldc
abcam
dilut
cellular
bactin
probe
load
control
mous
lung
slide
use
immunofluoresc
stain
antinucleoprotein
np
millipor
dilut
label
virusinfect
cell
describ
elsewher
zhou
et
al
imag
use
carl
zeiss
lsm
confoc
microscopi
mice
experi
nine
mice
group
evalu
mous
surviv
three
biolog
triplic
time
point
detect
infect
commonli
use
sampl
size
appropri
statist
analysi
minim
anim
use
inbr
cohous
mice
randomli
group
minim
subject
bia
blind
done
mous
surviv
data
analyz
mantelcox
test
experi
sampl
exclud
data
analysi
unpair
twosid
student
ttest
analysi
use
data
analysi
vitro
experi
perform
least
three
time
p
consid
statist
signific
data
present
mean
sd
repres
experi
expand
view
articl
avail
onlin
extracellular
environ
prevent
influenza
viru
matur
cell
paper
explain
host
gene
essenti
pathogenesi
influenza
virus
extens
investig
cellular
mous
studi
howev
identifi
host
gene
unabl
translat
clinic
implic
significantli
affect
diseas
manifest
influenza
patient
thu
remain
poorli
understood
host
gene
may
dictat
suscept
sever
influenza
human
gldc
priorit
potenti
suscept
gene
sever
influenza
integr
approach
base
exist
knowledg
uncov
gldcpyrimidin
biosynthesisinn
immun
axi
demonstr
gldc
inhibit
deplet
significantli
amplifi
antivir
respons
type
ifn
ifnstimul
gene
suppress
replic
virus
consist
gldc
overexpress
significantli
promot
viral
replic
due
attenu
antivir
respons
gldc
inhibit
balbc
mice
recapitul
amplifi
antivir
respons
suppress
viral
growth
indic
tempor
gldc
inhibit
could
achiev
potent
protect
infect
mice
fatal
infect
identifi
import
suscept
gene
sever
influenza
gldc
modul
antivir
respons
influenza
virus
therebi
impact
viral
growth
diseas
outcom
